Genome testing is useful, but eight beliefs distort what people expect from it: that genes are destiny, that one test finds everything, that a clean report means no risk, that ancestry percentages are exact, that consumer and clinical tests are interchangeable, that single genes control traits, that the law protects you from every kind of discrimination, and that your results never change.
Each is partly true, which is why they survive. The sections below separate the true part from the part that misleads.
The eight myths
1. "My genes decide what will happen to me"
A handful of conditions are close to deterministic. Huntington's disease is the textbook case, and our piece on predictive testing for Huntington's shows why that is rare. For most common conditions, a variant shifts probability and the outcome depends on many other genes, age, environment and chance. APOE e4 raises Alzheimer's risk without guaranteeing the disease, and plenty of carriers never develop it. Think "predisposition," not "prophecy." Our explainer on genetics versus epigenetics covers why the same DNA can play out differently.
2. "One DNA test reads everything"
Tests differ enormously in what they look at. A genotyping array checks a fixed list of known positions (our array versus sequencing comparison puts that at roughly 600,000 to 700,000). Whole genome sequencing reads far more, but even sequencing struggles with some variant types, such as large structural variants and repetitive regions. "Whole genome" describes how much of the DNA was read, not a promise that every finding was caught or understood.
3. "My report was clean, so I have no genetic risk"
A clean report means nothing was found among the things that were checked and understood. A targeted panel cannot flag what it did not examine, and the authors of a 2018 study of consumer results noted that such testing is often not comprehensive, so a negative result may not rule out a variant. Family history still matters. If several relatives had the same cancer or early heart disease, tell your doctor even if your report looks reassuring. See our guide to what genome testing can and cannot say about cancer risk.
4. "My ancestry percentages are exact"
They are statistical estimates. Companies compare your DNA with reference panels, and the answer depends on which panel, which regional boundaries and which algorithm version were used. That is why two companies can give different breakdowns for the same person, and why your own numbers can shift after an update. We walk through the mechanics in how ancestry percentages actually work, and in why siblings get different results.
5. "A consumer test is the same as a clinical test"
The chemistry may overlap, but the safeguards differ. In a 2018 study from a clinical genetics lab, 17 of 43 variants reported through consumer testing or third-party analysis of raw data (40%) were not found when the same people were retested clinically. The sample was small and self-selected, so it is not a national error rate, but the authors' conclusion is the practical rule: confirm anything that could change care. Our DTC versus clinical comparison explains the regulatory side, and why raw-data reports throw false alarms explains the technical side.
6. "There is a gene for that"
Headlines love a single culprit. Most traits people ask about, such as weight, height, mood or athletic ability, involve hundreds or thousands of small contributions. The famous FTO "obesity gene" is a good example: real signal, modest effect. Where a trait really is driven by many variants at once, scientists combine them into a score, which has its own limits (see polygenic risk scores explained).
7. "A law protects me from genetic discrimination"
Partly. In the United States, the federal GINA law bars health insurers and employers (of 15 or more people) from using genetic information, but it does not cover life, disability or long-term care insurance, and state rules vary. We lay out the gaps in our GINA explainer and the practical timing advice in life insurance and genetic testing. Outside the US, the rules are different again.
8. "My results are final"
Your DNA sequence does not change, but what scientists know about it does. A variant filed as "uncertain" can be reclassified as evidence grows, and a gene nobody linked to a condition today may be linked next year. That is the argument for keeping your raw files and rereading them periodically. We cover it in why your genome needs reanalysis and in our guide to variants of uncertain significance.
What the eight have in common
Each myth treats a probabilistic, evolving, method-dependent result as a fixed fact. The fix is the same every time: ask what was measured, how sure the lab is, and what the result changes about a real decision.
A practical filter. Before acting on any result, ask three questions. Which method produced it? Was it confirmed by a clinical laboratory? And would a doctor change anything because of it? If the answers are "an array," "no" and "yes," confirm first.
A genome you can reread as the science improves
Several of these myths come from treating a report as the whole story. Dante Labs delivers your raw data, so the file remains useful when interpretation changes.
Compare Dante Labs WGS → Code GENOME — 10% offAffiliate link. Consumer sequencing is not a clinical diagnostic. Confirm medically important findings through your doctor.
Bottom line
Genome testing earns its place when you treat it as one input: strong for some questions, weak for others, and open to revision. Match the test to the question, keep your raw data, and bring anything medically significant to a clinician before you act on it.
Common questions
Are consumer DNA tests accurate?
Accuracy depends on the question. Common variants read on an array are usually reliable, while very rare variants on those same arrays can be wrong far more often. In a large 2021 evaluation in The BMJ, only a small share of rare BRCA variants flagged by genotyping chips were confirmed by sequencing. Treat any result that could change medical care as a prompt for clinical confirmation.
Can a DNA test tell me whether I will get a disease?
Rarely with certainty. For a few single-gene conditions the answer is close to yes or no, but for most common diseases a result shifts risk up or down alongside age, lifestyle and family history.
Is whole genome sequencing better than a 23andMe-style array?
It reads far more of your DNA and gives you files you can reanalyze later, but it is not automatically clinical-grade and it still produces uncertain results. Our comparison guide goes through the trade-offs.
Do I need a genetic counselor to read my results?
Not for ancestry or curiosity, but a counselor is worth seeing for a concerning health finding or a strong family history. We cover when in do you need a genetic counselor.
How can I tell whether a scary result is real?
Check which method produced it, whether the variant is classified as pathogenic or only "associated," and whether a clinical lab has confirmed it. Do not stop medications or schedule surgery on the strength of a raw-data report alone.
Sources and verification
- Tandy-Connor et al., Genetics in Medicine (2018): false-positive results released by direct-to-consumer genetic tests (17 of 43 variants not confirmed; 49 patients, Ambry Genetics)
- Weedon et al., The BMJ (2021): use of SNP chips to detect rare pathogenic variants
Claims about GINA and array size repeat what our own guides state; see those pages for their references. Check current law in your jurisdiction.
Medical disclaimer. GenomeTesting.org publishes educational content about genetics and consumer genomic testing. Nothing here is medical advice, a diagnosis, or a substitute for care from a qualified clinician or genetic counsellor. Decisions about testing, treatment, or interpreting your own results should be made with a healthcare professional who can see your full history.
Affiliate disclosure. Some links on this page are affiliate links. If you buy through them we may earn a commission at no extra cost to you. This never changes which products we recommend or what we say about them.